Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Jan 3;17(1):65-71.
doi: 10.1097/00002030-200301030-00009.

Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya

James N Kiarie  1 , Joan K Kreiss, Barbra A Richardson, Grace C John-Stewart
Affiliations
Clinical Trial

Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya

James N Kiarie et al. AIDS. .

Abstract

Objective: To compare compliance and infant HIV-1 infection risk at 6 weeks with the Thai-CDC and HIVNET-012 antiretroviral regimens in a field setting.

Design: Randomized clinical trial.

Setting: Tertiary hospital antenatal clinic in Nairobi, Kenya.

Participants: HIV-1 infected women referred from primary care clinics.

Interventions: Thai-CDC zidovudine regimen or HIVNET-012 nevirapine regimen.

Main outcome measures: Women were considered compliant if they used >or= 80% of the doses. Infants were tested for HIV-1 at 6 weeks. RESULTS Seventy women were randomized to Thai-CDC and 69 to HIVNET-012 regimens. More women were compliant with the antenatal (86%) than the intrapartum (44%) Thai-CDC regimen doses ( P= 0.001). Ninety-seven per cent took the maternal and 91% gave the infant dose of the HIVNET-012 regimen (P = 0.2). Overall, 41% were compliant with the Thai-CDC regimen and 87% with the HIVNET-012 regimen ( P< 0.001). Compliance with the Thai-CDC regimen was associated with partner support of antiretroviral use [odds ratio (OR), 3.0;, 95% confidence interval (CI), 1.0-9.1] and knowledge at recruitment that antiretroviral drugs could prevent infant HIV-1 (OR, 2.9; 95% CI, 1.0-8.1). Compliance with the HIVNET-012 regimen was associated with partner notification (OR, 8.0; 95% CI, 1.5-50) and partner willingness to have HIV-1 testing (OR, 7.5; 95% CI, 1.4-40). There was a trend for a higher risk of transmission with the HIVNET-012 regimen than with the Thai-CDC regimen (22% versus 9%; P= 0.07).

Conclusion: Compliance with the Thai-CDC and HIVNET-012 regimens was comparable to that in efficacy trials. Partner involvement, support and education on perinatal HIV-1 prevention may improve compliance and increase the number of infants protected from HIV-1 infection.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Recruitment and follow-up of study subjects.
See this image and copyright information in PMC

References

    1. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802. - PubMed
    1. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. on behalf of the Bangkok Collaborative Perinatal HIV Transmission Study Group Short-course zidovudine for perinatal HIV-1 transmission in Bangok, Thailand: a randomized controlled trial. Lancet. 1999;353:773–780. - PubMed
    1. UNAIDS. WHO Report on the global HIV/AIDS epidemic: Global HIV/AIDS and STD Surveillance. 2000 http://www.unaids.org/epidemic_update/report/index.html.
    1. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al. Short course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d’Ivoire: a randomized trial. Lancet. 1999;353:781–785. - PubMed
    1. Statistics Division of the United Nations Secretariat and International Labour Office Indicators of income and economic activity. 1999 http://www.un.org/depts/unstd/social/inc-eco.htm.

Publication types

MeSH terms